Thalidomide toxicity in patients with AL (primary) amyloidosis.

被引：0
|
作者：
Palladini, G [1 ]
Perfetti, V [1 ]
Obici, L [1 ]
Merlini, G [1 ]
机构：
[1] Univ Pavia, Univ Hosp IRCCS Policlin San Matteo, Biotechnol Res Labs, Dept Biochem, I-27100 Pavia, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1543
引用
收藏
页码：397A / 397A
页数：1
相关论文
共 50 条
  • [21] The role of renal transplantation in systemic AL amyloidosis.
    Wechalekar, AD
    Lachmann, HJ
    Gillmore, JD
    Goodman, HJB
    Offer, M
    Hawkins, PN
    BLOOD, 2005, 106 (11) : 976A - 977A
  • [22] Characterization of amyloidogenic light chains from patients diagnosed with primary amyloidosis.
    Lim, A
    McComb, ME
    Prokaeva, T
    Connors, LH
    Walsh, MT
    Skinner, M
    Costello, CE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U131 - U131
  • [23] A single institution review of cases of AL amyloidosis.
    Sumpter, K
    Powles, R
    Raje, N
    Kulkarni, S
    Ramiah, V
    Hill, M
    Horton, C
    Milan, S
    Mehta, J
    Singhal, S
    Treleaven, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S210 - S210
  • [24] Single institution review of cases of AL amyloidosis.
    Sumpter, K
    Powles, R
    Raje, N
    Kulkarni, S
    Ramiah, V
    Hill, M
    Horton, C
    Milan, S
    Mehta, J
    Singhal, S
    Rodriguez, M
    Mateos, P
    Laufente, A
    Treleaven, J
    BLOOD, 1997, 90 (10) : 4583 - 4583
  • [25] Primary localized nasopharyngeal amyloidosis. A case report
    Dominguez, S
    Wienberg, P
    Claros, P
    Claros, A
    Vila, J
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1996, 36 (01) : 61 - 67
  • [26] Arterial-myocardial coupling in primary AL amyloidosis. A validation study of vascular involvement
    Patras, R.
    Delialis, D.
    Petropoulos, I
    Georgiopoulos, G.
    Theodarakakou, F.
    Bampatsias, D.
    Angelidakis, L.
    Alexandropoulos, A.
    Zervas, G.
    Moustou, C.
    Rachiotis, N.
    Dimopoulos, M. A.
    Briasoulis, A.
    Kastritis, E.
    Stamatelopoulos, K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Stem cell transplantation for management of primary amyloidosis.
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Gastineau, DA
    Chen, MG
    Ansell, SM
    Inwards, DJ
    Micallef, IN
    Tefferi, A
    Litzow, MR
    BLOOD, 2001, 98 (11) : 816A - 816A
  • [28] The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)
    Palladini, G
    Perfetti, V
    Perlini, S
    Obici, L
    Lavatelli, F
    Caccialanza, R
    Invernizzi, R
    Comotti, B
    Merlini, G
    BLOOD, 2005, 105 (07) : 2949 - 2951
  • [29] Kidney transplantation in patients with systemic amyloidosis.
    Wien, Tale N.
    Leivestad, Torborn
    Reisaeter, Anna V.
    Witczak, Bartlomiej J.
    Foss, Aksel
    Hartmann, Anders
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 217 - 217
  • [30] Lenalidomide has activity in a phase II trial in patients with primary systemic amyloidosis.
    Dispenzieri, A
    Lacy, MQ
    Zeldenrust, SR
    Geyer, SM
    Lust, JA
    Hayman, SR
    Kumar, SK
    Allred, JB
    Rajkumar, SV
    Kabat, B
    Witzig, TE
    Greipp, PR
    Russell, SR
    Ghobrial, I
    Gertz, MA
    BLOOD, 2005, 106 (11) : 77A - 77A
12345